Global Biologic Therapeutics Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Biologic Therapeutics Drugs market size was valued at USD 331750 million in 2023 and is forecast to a readjusted size of USD 490710 million by 2030 with a CAGR of 5.8% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biologic Therapeutics Drugs industry chain, the market status of Rheumatoid Arthritis (Avian Cell Culture, Yeast), Anemia (Avian Cell Culture, Yeast), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologic Therapeutics Drugs.
Regionally, the report analyzes the Biologic Therapeutics Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologic Therapeutics Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologic Therapeutics Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologic Therapeutics Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Avian Cell Culture, Yeast).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologic Therapeutics Drugs market.
Regional Analysis: The report involves examining the Biologic Therapeutics Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologic Therapeutics Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologic Therapeutics Drugs:
Company Analysis: Report covers individual Biologic Therapeutics Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologic Therapeutics Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rheumatoid Arthritis, Anemia).
Technology Analysis: Report covers specific technologies relevant to Biologic Therapeutics Drugs. It assesses the current state, advancements, and potential future developments in Biologic Therapeutics Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologic Therapeutics Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologic Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Biologic Therapeutics Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologic Therapeutics Drugs, with price, sales, revenue and global market share of Biologic Therapeutics Drugs from 2019 to 2024.
Chapter 3, the Biologic Therapeutics Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Therapeutics Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics Drugs.
Chapter 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Biologic Therapeutics Drugs industry chain, the market status of Rheumatoid Arthritis (Avian Cell Culture, Yeast), Anemia (Avian Cell Culture, Yeast), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Biologic Therapeutics Drugs.
Regionally, the report analyzes the Biologic Therapeutics Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Biologic Therapeutics Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Biologic Therapeutics Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Biologic Therapeutics Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Avian Cell Culture, Yeast).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Biologic Therapeutics Drugs market.
Regional Analysis: The report involves examining the Biologic Therapeutics Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Biologic Therapeutics Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Biologic Therapeutics Drugs:
Company Analysis: Report covers individual Biologic Therapeutics Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Biologic Therapeutics Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Rheumatoid Arthritis, Anemia).
Technology Analysis: Report covers specific technologies relevant to Biologic Therapeutics Drugs. It assesses the current state, advancements, and potential future developments in Biologic Therapeutics Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Biologic Therapeutics Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Biologic Therapeutics Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Avian Cell Culture
- Yeast
- Bacteria
- Insects Cell Culture
- Transgenics
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
- Pfizer
- AstraZeneca
- Novartis
- Merck
- Smith Medical
- GlaxoSmithKline
- Concord Biotech
- Aurobindo Pharma
- H. Lundbeck
- Retractable Technologies
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Biologic Therapeutics Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Biologic Therapeutics Drugs, with price, sales, revenue and global market share of Biologic Therapeutics Drugs from 2019 to 2024.
Chapter 3, the Biologic Therapeutics Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Therapeutics Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Biologic Therapeutics Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Biologic Therapeutics Drugs.
Chapter 14 and 15, to describe Biologic Therapeutics Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologic Therapeutics Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Avian Cell Culture
1.3.3 Yeast
1.3.4 Bacteria
1.3.5 Insects Cell Culture
1.3.6 Transgenics
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologic Therapeutics Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Global Biologic Therapeutics Drugs Market Size & Forecast
1.5.1 Global Biologic Therapeutics Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biologic Therapeutics Drugs Sales Quantity (2019-2030)
1.5.3 Global Biologic Therapeutics Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biologic Therapeutics Drugs Product and Services
2.1.4 Pfizer Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Biologic Therapeutics Drugs Product and Services
2.2.4 AstraZeneca Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Biologic Therapeutics Drugs Product and Services
2.3.4 Novartis Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Therapeutics Drugs Product and Services
2.4.4 Merck Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Smith Medical
2.5.1 Smith Medical Details
2.5.2 Smith Medical Major Business
2.5.3 Smith Medical Biologic Therapeutics Drugs Product and Services
2.5.4 Smith Medical Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Smith Medical Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Product and Services
2.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Concord Biotech
2.7.1 Concord Biotech Details
2.7.2 Concord Biotech Major Business
2.7.3 Concord Biotech Biologic Therapeutics Drugs Product and Services
2.7.4 Concord Biotech Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Concord Biotech Recent Developments/Updates
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Product and Services
2.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Aurobindo Pharma Recent Developments/Updates
2.9 H. Lundbeck
2.9.1 H. Lundbeck Details
2.9.2 H. Lundbeck Major Business
2.9.3 H. Lundbeck Biologic Therapeutics Drugs Product and Services
2.9.4 H. Lundbeck Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 H. Lundbeck Recent Developments/Updates
2.10 Retractable Technologies
2.10.1 Retractable Technologies Details
2.10.2 Retractable Technologies Major Business
2.10.3 Retractable Technologies Biologic Therapeutics Drugs Product and Services
2.10.4 Retractable Technologies Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Retractable Technologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGIC THERAPEUTICS DRUGS BY MANUFACTURER
3.1 Global Biologic Therapeutics Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biologic Therapeutics Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Biologic Therapeutics Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biologic Therapeutics Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Biologic Therapeutics Drugs Manufacturer Market Share in 2023
3.5 Biologic Therapeutics Drugs Market: Overall Company Footprint Analysis
3.5.1 Biologic Therapeutics Drugs Market: Region Footprint
3.5.2 Biologic Therapeutics Drugs Market: Company Product Type Footprint
3.5.3 Biologic Therapeutics Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologic Therapeutics Drugs Market Size by Region
4.1.1 Global Biologic Therapeutics Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Biologic Therapeutics Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Biologic Therapeutics Drugs Average Price by Region (2019-2030)
4.2 North America Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.3 Europe Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.5 South America Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Biologic Therapeutics Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
5.2 Global Biologic Therapeutics Drugs Consumption Value by Type (2019-2030)
5.3 Global Biologic Therapeutics Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
6.2 Global Biologic Therapeutics Drugs Consumption Value by Application (2019-2030)
6.3 Global Biologic Therapeutics Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
7.2 North America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
7.3 North America Biologic Therapeutics Drugs Market Size by Country
7.3.1 North America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Biologic Therapeutics Drugs Market Size by Country
8.3.1 Europe Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biologic Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
10.2 South America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
10.3 South America Biologic Therapeutics Drugs Market Size by Country
10.3.1 South America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biologic Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biologic Therapeutics Drugs Market Drivers
12.2 Biologic Therapeutics Drugs Market Restraints
12.3 Biologic Therapeutics Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologic Therapeutics Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologic Therapeutics Drugs
13.3 Biologic Therapeutics Drugs Production Process
13.4 Biologic Therapeutics Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologic Therapeutics Drugs Typical Distributors
14.3 Biologic Therapeutics Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Biologic Therapeutics Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Avian Cell Culture
1.3.3 Yeast
1.3.4 Bacteria
1.3.5 Insects Cell Culture
1.3.6 Transgenics
1.4 Market Analysis by Application
1.4.1 Overview: Global Biologic Therapeutics Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Rheumatoid Arthritis
1.4.3 Anemia
1.4.4 Cancer
1.4.5 Diabetes
1.4.6 Others
1.5 Global Biologic Therapeutics Drugs Market Size & Forecast
1.5.1 Global Biologic Therapeutics Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Biologic Therapeutics Drugs Sales Quantity (2019-2030)
1.5.3 Global Biologic Therapeutics Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Biologic Therapeutics Drugs Product and Services
2.1.4 Pfizer Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 AstraZeneca
2.2.1 AstraZeneca Details
2.2.2 AstraZeneca Major Business
2.2.3 AstraZeneca Biologic Therapeutics Drugs Product and Services
2.2.4 AstraZeneca Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AstraZeneca Recent Developments/Updates
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Biologic Therapeutics Drugs Product and Services
2.3.4 Novartis Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Novartis Recent Developments/Updates
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Biologic Therapeutics Drugs Product and Services
2.4.4 Merck Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Merck Recent Developments/Updates
2.5 Smith Medical
2.5.1 Smith Medical Details
2.5.2 Smith Medical Major Business
2.5.3 Smith Medical Biologic Therapeutics Drugs Product and Services
2.5.4 Smith Medical Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Smith Medical Recent Developments/Updates
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business
2.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Product and Services
2.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 GlaxoSmithKline Recent Developments/Updates
2.7 Concord Biotech
2.7.1 Concord Biotech Details
2.7.2 Concord Biotech Major Business
2.7.3 Concord Biotech Biologic Therapeutics Drugs Product and Services
2.7.4 Concord Biotech Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Concord Biotech Recent Developments/Updates
2.8 Aurobindo Pharma
2.8.1 Aurobindo Pharma Details
2.8.2 Aurobindo Pharma Major Business
2.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Product and Services
2.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Aurobindo Pharma Recent Developments/Updates
2.9 H. Lundbeck
2.9.1 H. Lundbeck Details
2.9.2 H. Lundbeck Major Business
2.9.3 H. Lundbeck Biologic Therapeutics Drugs Product and Services
2.9.4 H. Lundbeck Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 H. Lundbeck Recent Developments/Updates
2.10 Retractable Technologies
2.10.1 Retractable Technologies Details
2.10.2 Retractable Technologies Major Business
2.10.3 Retractable Technologies Biologic Therapeutics Drugs Product and Services
2.10.4 Retractable Technologies Biologic Therapeutics Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Retractable Technologies Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BIOLOGIC THERAPEUTICS DRUGS BY MANUFACTURER
3.1 Global Biologic Therapeutics Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Biologic Therapeutics Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Biologic Therapeutics Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Biologic Therapeutics Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Biologic Therapeutics Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Biologic Therapeutics Drugs Manufacturer Market Share in 2023
3.5 Biologic Therapeutics Drugs Market: Overall Company Footprint Analysis
3.5.1 Biologic Therapeutics Drugs Market: Region Footprint
3.5.2 Biologic Therapeutics Drugs Market: Company Product Type Footprint
3.5.3 Biologic Therapeutics Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Biologic Therapeutics Drugs Market Size by Region
4.1.1 Global Biologic Therapeutics Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Biologic Therapeutics Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Biologic Therapeutics Drugs Average Price by Region (2019-2030)
4.2 North America Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.3 Europe Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.5 South America Biologic Therapeutics Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Biologic Therapeutics Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
5.2 Global Biologic Therapeutics Drugs Consumption Value by Type (2019-2030)
5.3 Global Biologic Therapeutics Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
6.2 Global Biologic Therapeutics Drugs Consumption Value by Application (2019-2030)
6.3 Global Biologic Therapeutics Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
7.2 North America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
7.3 North America Biologic Therapeutics Drugs Market Size by Country
7.3.1 North America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Biologic Therapeutics Drugs Market Size by Country
8.3.1 Europe Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Biologic Therapeutics Drugs Market Size by Region
9.3.1 Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
10.2 South America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
10.3 South America Biologic Therapeutics Drugs Market Size by Country
10.3.1 South America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Biologic Therapeutics Drugs Market Size by Country
11.3.1 Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Biologic Therapeutics Drugs Market Drivers
12.2 Biologic Therapeutics Drugs Market Restraints
12.3 Biologic Therapeutics Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Biologic Therapeutics Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biologic Therapeutics Drugs
13.3 Biologic Therapeutics Drugs Production Process
13.4 Biologic Therapeutics Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Biologic Therapeutics Drugs Typical Distributors
14.3 Biologic Therapeutics Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologic Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biologic Therapeutics Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biologic Therapeutics Drugs Product and Services
Table 6. Pfizer Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Biologic Therapeutics Drugs Product and Services
Table 11. AstraZeneca Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Biologic Therapeutics Drugs Product and Services
Table 16. Novartis Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Biologic Therapeutics Drugs Product and Services
Table 21. Merck Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Smith Medical Basic Information, Manufacturing Base and Competitors
Table 24. Smith Medical Major Business
Table 25. Smith Medical Biologic Therapeutics Drugs Product and Services
Table 26. Smith Medical Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Smith Medical Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Biologic Therapeutics Drugs Product and Services
Table 31. GlaxoSmithKline Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Concord Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Concord Biotech Major Business
Table 35. Concord Biotech Biologic Therapeutics Drugs Product and Services
Table 36. Concord Biotech Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Concord Biotech Recent Developments/Updates
Table 38. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Aurobindo Pharma Major Business
Table 40. Aurobindo Pharma Biologic Therapeutics Drugs Product and Services
Table 41. Aurobindo Pharma Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Aurobindo Pharma Recent Developments/Updates
Table 43. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 44. H. Lundbeck Major Business
Table 45. H. Lundbeck Biologic Therapeutics Drugs Product and Services
Table 46. H. Lundbeck Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. H. Lundbeck Recent Developments/Updates
Table 48. Retractable Technologies Basic Information, Manufacturing Base and Competitors
Table 49. Retractable Technologies Major Business
Table 50. Retractable Technologies Biologic Therapeutics Drugs Product and Services
Table 51. Retractable Technologies Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Retractable Technologies Recent Developments/Updates
Table 53. Global Biologic Therapeutics Drugs Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Biologic Therapeutics Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Biologic Therapeutics Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Biologic Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Biologic Therapeutics Drugs Production Site of Key Manufacturer
Table 58. Biologic Therapeutics Drugs Market: Company Product Type Footprint
Table 59. Biologic Therapeutics Drugs Market: Company Product Application Footprint
Table 60. Biologic Therapeutics Drugs New Market Entrants and Barriers to Market Entry
Table 61. Biologic Therapeutics Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 63. Global Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 64. Global Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Biologic Therapeutics Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Biologic Therapeutics Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 69. Global Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 70. Global Biologic Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Biologic Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Biologic Therapeutics Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Biologic Therapeutics Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 75. Global Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 76. Global Biologic Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Biologic Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Biologic Therapeutics Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Biologic Therapeutics Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 81. North America Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 82. North America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 83. North America Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 84. North America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 85. North America Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 86. North America Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 89. Europe Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 90. Europe Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 91. Europe Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 92. Europe Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 93. Europe Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 94. Europe Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 97. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 98. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 99. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 100. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 101. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 102. Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 105. South America Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 106. South America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 107. South America Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 108. South America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 109. South America Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 110. South America Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 113. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 114. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 115. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 116. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 117. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 118. Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Biologic Therapeutics Drugs Raw Material
Table 121. Key Manufacturers of Biologic Therapeutics Drugs Raw Materials
Table 122. Biologic Therapeutics Drugs Typical Distributors
Table 123. Biologic Therapeutics Drugs Typical Customers
Table 1. Global Biologic Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Biologic Therapeutics Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Biologic Therapeutics Drugs Product and Services
Table 6. Pfizer Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 9. AstraZeneca Major Business
Table 10. AstraZeneca Biologic Therapeutics Drugs Product and Services
Table 11. AstraZeneca Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AstraZeneca Recent Developments/Updates
Table 13. Novartis Basic Information, Manufacturing Base and Competitors
Table 14. Novartis Major Business
Table 15. Novartis Biologic Therapeutics Drugs Product and Services
Table 16. Novartis Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Novartis Recent Developments/Updates
Table 18. Merck Basic Information, Manufacturing Base and Competitors
Table 19. Merck Major Business
Table 20. Merck Biologic Therapeutics Drugs Product and Services
Table 21. Merck Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Merck Recent Developments/Updates
Table 23. Smith Medical Basic Information, Manufacturing Base and Competitors
Table 24. Smith Medical Major Business
Table 25. Smith Medical Biologic Therapeutics Drugs Product and Services
Table 26. Smith Medical Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Smith Medical Recent Developments/Updates
Table 28. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 29. GlaxoSmithKline Major Business
Table 30. GlaxoSmithKline Biologic Therapeutics Drugs Product and Services
Table 31. GlaxoSmithKline Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. GlaxoSmithKline Recent Developments/Updates
Table 33. Concord Biotech Basic Information, Manufacturing Base and Competitors
Table 34. Concord Biotech Major Business
Table 35. Concord Biotech Biologic Therapeutics Drugs Product and Services
Table 36. Concord Biotech Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Concord Biotech Recent Developments/Updates
Table 38. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Aurobindo Pharma Major Business
Table 40. Aurobindo Pharma Biologic Therapeutics Drugs Product and Services
Table 41. Aurobindo Pharma Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Aurobindo Pharma Recent Developments/Updates
Table 43. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 44. H. Lundbeck Major Business
Table 45. H. Lundbeck Biologic Therapeutics Drugs Product and Services
Table 46. H. Lundbeck Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. H. Lundbeck Recent Developments/Updates
Table 48. Retractable Technologies Basic Information, Manufacturing Base and Competitors
Table 49. Retractable Technologies Major Business
Table 50. Retractable Technologies Biologic Therapeutics Drugs Product and Services
Table 51. Retractable Technologies Biologic Therapeutics Drugs Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Retractable Technologies Recent Developments/Updates
Table 53. Global Biologic Therapeutics Drugs Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Biologic Therapeutics Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Biologic Therapeutics Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Biologic Therapeutics Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Biologic Therapeutics Drugs Production Site of Key Manufacturer
Table 58. Biologic Therapeutics Drugs Market: Company Product Type Footprint
Table 59. Biologic Therapeutics Drugs Market: Company Product Application Footprint
Table 60. Biologic Therapeutics Drugs New Market Entrants and Barriers to Market Entry
Table 61. Biologic Therapeutics Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 63. Global Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 64. Global Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Biologic Therapeutics Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Biologic Therapeutics Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 69. Global Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 70. Global Biologic Therapeutics Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Biologic Therapeutics Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Biologic Therapeutics Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Biologic Therapeutics Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 75. Global Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 76. Global Biologic Therapeutics Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Biologic Therapeutics Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Biologic Therapeutics Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Biologic Therapeutics Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 81. North America Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 82. North America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 83. North America Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 84. North America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 85. North America Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 86. North America Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 89. Europe Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 90. Europe Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 91. Europe Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 92. Europe Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 93. Europe Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 94. Europe Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 97. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 98. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 99. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 100. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 101. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 102. Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 105. South America Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 106. South America Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 107. South America Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 108. South America Biologic Therapeutics Drugs Sales Quantity by Country (2019-2024) & (Units)
Table 109. South America Biologic Therapeutics Drugs Sales Quantity by Country (2025-2030) & (Units)
Table 110. South America Biologic Therapeutics Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Biologic Therapeutics Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2019-2024) & (Units)
Table 113. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Type (2025-2030) & (Units)
Table 114. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2019-2024) & (Units)
Table 115. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Application (2025-2030) & (Units)
Table 116. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Region (2019-2024) & (Units)
Table 117. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity by Region (2025-2030) & (Units)
Table 118. Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Biologic Therapeutics Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Biologic Therapeutics Drugs Raw Material
Table 121. Key Manufacturers of Biologic Therapeutics Drugs Raw Materials
Table 122. Biologic Therapeutics Drugs Typical Distributors
Table 123. Biologic Therapeutics Drugs Typical Customers
LIST OF FIGURES
Figure 1. Biologic Therapeutics Drugs Picture
Figure 2. Global Biologic Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologic Therapeutics Drugs Consumption Value Market Share by Type in 2023
Figure 4. Avian Cell Culture Examples
Figure 5. Yeast Examples
Figure 6. Bacteria Examples
Figure 7. Insects Cell Culture Examples
Figure 8. Transgenics Examples
Figure 9. Global Biologic Therapeutics Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Biologic Therapeutics Drugs Consumption Value Market Share by Application in 2023
Figure 11. Rheumatoid Arthritis Examples
Figure 12. Anemia Examples
Figure 13. Cancer Examples
Figure 14. Diabetes Examples
Figure 15. Others Examples
Figure 16. Global Biologic Therapeutics Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Biologic Therapeutics Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Biologic Therapeutics Drugs Sales Quantity (2019-2030) & (Units)
Figure 19. Global Biologic Therapeutics Drugs Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Biologic Therapeutics Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Biologic Therapeutics Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Biologic Therapeutics Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Biologic Therapeutics Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Biologic Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Biologic Therapeutics Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Biologic Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Biologic Therapeutics Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 58. China Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Biologic Therapeutics Drugs Market Drivers
Figure 79. Biologic Therapeutics Drugs Market Restraints
Figure 80. Biologic Therapeutics Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Biologic Therapeutics Drugs in 2023
Figure 83. Manufacturing Process Analysis of Biologic Therapeutics Drugs
Figure 84. Biologic Therapeutics Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Biologic Therapeutics Drugs Picture
Figure 2. Global Biologic Therapeutics Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Biologic Therapeutics Drugs Consumption Value Market Share by Type in 2023
Figure 4. Avian Cell Culture Examples
Figure 5. Yeast Examples
Figure 6. Bacteria Examples
Figure 7. Insects Cell Culture Examples
Figure 8. Transgenics Examples
Figure 9. Global Biologic Therapeutics Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Biologic Therapeutics Drugs Consumption Value Market Share by Application in 2023
Figure 11. Rheumatoid Arthritis Examples
Figure 12. Anemia Examples
Figure 13. Cancer Examples
Figure 14. Diabetes Examples
Figure 15. Others Examples
Figure 16. Global Biologic Therapeutics Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Biologic Therapeutics Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Biologic Therapeutics Drugs Sales Quantity (2019-2030) & (Units)
Figure 19. Global Biologic Therapeutics Drugs Average Price (2019-2030) & (USD/Unit)
Figure 20. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 21. Global Biologic Therapeutics Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 22. Producer Shipments of Biologic Therapeutics Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 23. Top 3 Biologic Therapeutics Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Top 6 Biologic Therapeutics Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 26. Global Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 27. North America Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. Europe Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Asia-Pacific Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. South America Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 31. Middle East & Africa Biologic Therapeutics Drugs Consumption Value (2019-2030) & (USD Million)
Figure 32. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 33. Global Biologic Therapeutics Drugs Consumption Value Market Share by Type (2019-2030)
Figure 34. Global Biologic Therapeutics Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 35. Global Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Biologic Therapeutics Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. Global Biologic Therapeutics Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 38. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 39. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 41. North America Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 42. United States Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Canada Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Mexico Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 46. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 47. Europe Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 48. Europe Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 49. Germany Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. France Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. United Kingdom Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Russia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Italy Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 55. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 56. Asia-Pacific Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 57. Asia-Pacific Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 58. China Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Japan Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Korea Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. India Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Southeast Asia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Australia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 65. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 66. South America Biologic Therapeutics Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 67. South America Biologic Therapeutics Drugs Consumption Value Market Share by Country (2019-2030)
Figure 68. Brazil Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Argentina Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 71. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 72. Middle East & Africa Biologic Therapeutics Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 73. Middle East & Africa Biologic Therapeutics Drugs Consumption Value Market Share by Region (2019-2030)
Figure 74. Turkey Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Egypt Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Saudi Arabia Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. South Africa Biologic Therapeutics Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. Biologic Therapeutics Drugs Market Drivers
Figure 79. Biologic Therapeutics Drugs Market Restraints
Figure 80. Biologic Therapeutics Drugs Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Biologic Therapeutics Drugs in 2023
Figure 83. Manufacturing Process Analysis of Biologic Therapeutics Drugs
Figure 84. Biologic Therapeutics Drugs Industrial Chain
Figure 85. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
